Sensus Healthcare (NASDAQ:SRTS – Get Free Report) and Inogen (NASDAQ:INGN – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings.
Volatility and Risk
Sensus Healthcare has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Inogen has a beta of 1.57, meaning that its stock price is 57% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for Sensus Healthcare and Inogen, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sensus Healthcare | 1 | 1 | 4 | 0 | 2.50 |
| Inogen | 1 | 0 | 0 | 1 | 2.50 |
Valuation and Earnings
This table compares Sensus Healthcare and Inogen”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sensus Healthcare | $27.48 million | 1.86 | -$7.72 million | ($0.94) | -3.30 |
| Inogen | $354.30 million | 0.39 | -$22.75 million | ($0.90) | -5.73 |
Sensus Healthcare has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by insiders. Comparatively, 2.5% of Inogen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Profitability
This table compares Sensus Healthcare and Inogen’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sensus Healthcare | -88.45% | -21.57% | -19.20% |
| Inogen | -6.94% | -13.17% | -8.36% |
Summary
Inogen beats Sensus Healthcare on 8 of the 14 factors compared between the two stocks.
About Sensus Healthcare
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
About Inogen
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Receive News & Ratings for Sensus Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
